Emboflu is a medical device company, which manufactures an
embolic liquid for the treatment of Arterio-Venous Malformations.
Emboflu is headquartered in Switzerland and distributes across
the world through a network of dedicated partners.

Our mission

We are commited in improving the treatment of vascular
malformations by bringing new solutions to the Practitioner.
We aim to become leaders in innovating technologies, that make
a valuable difference in the pratice of physicians and ultimately,
in patients' lives.

Company quality certificates an registrations

CE Mark (2012)

ISO 13485 (2012)